Literature DB >> 17230453

Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's.

Kelvin L Chou1, Maria L Moro-De-Casillas, Melissa M Amick, Leora L Borek, Joseph H Friedman.   

Abstract

We examined the relationship between testosterone levels, violent dreams, and REM sleep behavior disorder (RBD) in 31 men with Parkinson's disease (PD): 12 with clinical RBD and 19 without. All PD patients with clinical RBD experienced violent dreams, but none of the 19 non-RBD patients reported violent dreams. While dream content appears to be more aggressive in PD patients with clinical RBD, the presence of violent dreams or clinical RBD is not associated with testosterone levels in men with PD.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17230453     DOI： 10.1002/mds.21339

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  5 in total

Review 1.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

2.  Phasic muscle activity in sleep and clinical features of Parkinson disease.

Authors:  Donald L Bliwise; Lynn Marie Trotti; Sophia A Greer; Jorge J Juncos; David B Rye
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

3.  Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease.

Authors:  Abidemi I Otaiku
Journal:  Mov Disord Clin Pract       Date:  2021-08-09

4.  Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort.

Authors:  Michael S Okun; Samuel S Wu; Dana Jennings; Kenneth Marek; Ramon L Rodriguez; Hubert H Fernandez
Journal:  J Clin Mov Disord       Date:  2014-11-26

Review 5.  A Neurologist's Guide to REM Sleep Behavior Disorder.

Authors:  Amber Roguski; Dane Rayment; Alan L Whone; Matt W Jones; Michal Rolinski
Journal:  Front Neurol       Date:  2020-07-08       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.